In Vitro Effects of SB202190 on Echinococcus granulosus
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Spillage of cyst contents during surgical operation is the major cause of recurrence after hydatid cyst surgery. Instillation of a scolicidal agent into a hepatic hydatid cyst is the most commonly employed measure to prevent this complication. SB202190 is a pyridinyl imidazole derivative and is known to be a specific inhibitor of p38 MAPK. In the present study, the scolicidal effect of SB202190 was investigated. Freshly isolated Echinococcus granulosus protoscolices were subjected to SB202190treatment (10, 20, 40, and 80 μM), and the effects on parasite viability were monitored by trypan blue staining. Corresponding effects were visualized by scanning and transmission electron microscopy. Dose-dependent protoscolex death within a few days of SB202190 treatment was observed. Although the in vitro scolicidal effect of SB202190 was satisfactory, the in vivo efficacy of this drug and also possible side effects remain to be further investigated.
Abstract
Spillage of cyst contents during surgical operation is the major cause of recurrence after hydatid cyst surgery. Instillation of a scolicidal agent into a hepatic hydatid cyst is the most commonly employed measure to prevent this complication. SB202190 is a pyridinyl imidazole derivative and is known to be a specific inhibitor of p38 MAPK. In the present study, the scolicidal effect of SB202190 was investigated. Freshly isolated Echinococcus granulosus protoscolices were subjected to SB202190treatment (10, 20, 40, and 80 μM), and the effects on parasite viability were monitored by trypan blue staining. Corresponding effects were visualized by scanning and transmission electron microscopy. Dose-dependent protoscolex death within a few days of SB202190 treatment was observed. Although the in vitro scolicidal effect of SB202190 was satisfactory, the in vivo efficacy of this drug and also possible side effects remain to be further investigated.
참고문헌 (13)
- McManus DP, "Echinococcosis", Lancet, 362, pp.1295~1304 (2003)
- Moro P, "Echinococcosis: a review", Int J Infect Dis, 13, pp.125~133 (2009)
- Tozar E, "The effects of cetrimide-chlorhexidine combination on the hepatopancreatico- biliary system", World J Surg, 29, pp.754~758 (2005)
- Topcu O, "Efficacy of chlorhexidine gluconate during surgery for hydatid cyst", World J Surg, 33, pp.1274~1280 (2009)
- Moazeni M, "In vitro effectiveness of acidic and alkline solutions on scolices of hydatid cyst", Parasitol Res, 106, pp.853~856 (2010)
- Yong HY, Koh MS, Moon A, "The p38 mapk inhibitors for the treatment of inflammatory diseases and cancer", Expert Opin Investig Drugs 2009;, 18, pp.1893~1905
- -pyridin-2-yl}-(1-phenylethyl)-amine), a 4-pyridinylimidazole-type p38 mitogen-activated protein kinase inhibitor, "Drug Metab Dispos", 2007, 875~883
- Gelmedin V, "Characterization and inhibition of a p38-like mitogen-activated protein kinase(MAPK)from Echinococcus multilocularis : antiparasitic activities of p38 MAPK inhibitors", Biochem Pharmacol, 76, pp.1068~1081 (2008)
- Kapan M, "Postoperative recurrence in hepatic hydatid disease", J Gastrointest Surg, 10, pp.734~739 (2006)
- Albi A, "Severe hypernatremia after hypertonic saline irrigation of hydatid cysts", Anesth Analg, 95, pp.1806~1808 (2002)
- Caglar R, "In vitro effectiveness of different chemical agents on scolices of hydatid cyst", J Invest Surg, 21, pp.71~75 (2008)
- Paillas S, "Targeting the p38 MAPK pathway inhibits irinotecan resistance in colon adenocarcinoma", Cancer Res, 71, pp.1041~1049 (2011)
- Brumlik MJ, "Human p38 mitogen-activated protein kinase inhibitor drugs inhibit Plasmodium falciparum replication", Exp Parasitol, 128, pp.170~175 (2011)